Webster Santos
Fondatore presso SphynKx Therapeutics LLC
Profilo
Webster Santos is the founder of SphynKx Therapeutics LLC, which he founded in 2010 and where he holds the title of Vice President-Medicinal Chemistry.
He is currently the President, Chief Executive Officer & Director at Continuum Biosciences, Inc., a position he has held since 2017.
Dr. Santos received his undergraduate and doctorate degrees from the University of Virginia.
Posizioni attive di Webster Santos
| Società | Posizione | Inizio |
|---|---|---|
SphynKx Therapeutics LLC
 SphynKx Therapeutics LLC Pharmaceuticals: MajorHealth Technology SphynKx Therapeutics LLC engages in developing, discovering and commercializing novel therapies for the treatment of fibrosis. Its Sphingosine 1-phosphate (S1P) is recognized as a key regulator of many of the cellular processes that promote wound healing and fibrogenesis, which include fibroblast and immune cell migration, vascular leak, proliferation, angiogenesis, and TGF-ß signaling. The company was founded by Andrew Bolt, Kevin R. Lynch, Webster Santos and Timothy L. Macdonald in 2010 and is headquartered in Charlottesville, VA. | Fondatore | 01/01/2010 |
Continuum Biosciences, Inc.
 Continuum Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Continuum Biosciences, Inc. operates as a biotech company that focuses on diseases such as obesity, diabetes, and ageing. The company was founded in 2017 and is headquartered in Blacksburg, VA. | Amministratore Delegato | 15/08/2017 |
Formazione di Webster Santos
| University of Virginia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
SphynKx Therapeutics LLC
SphynKx Therapeutics LLC Pharmaceuticals: MajorHealth Technology SphynKx Therapeutics LLC engages in developing, discovering and commercializing novel therapies for the treatment of fibrosis. Its Sphingosine 1-phosphate (S1P) is recognized as a key regulator of many of the cellular processes that promote wound healing and fibrogenesis, which include fibroblast and immune cell migration, vascular leak, proliferation, angiogenesis, and TGF-ß signaling. The company was founded by Andrew Bolt, Kevin R. Lynch, Webster Santos and Timothy L. Macdonald in 2010 and is headquartered in Charlottesville, VA. | Health Technology |
Continuum Biosciences, Inc.
Continuum Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Continuum Biosciences, Inc. operates as a biotech company that focuses on diseases such as obesity, diabetes, and ageing. The company was founded in 2017 and is headquartered in Blacksburg, VA. | Commercial Services |
- Borsa valori
- Insiders
- Webster Santos
